Pharma Reviews: Indian pharma faces challenging times, revenue growth only 9.4% in Q2: ICRA

ICRA expects growth trajectory for Indian pharmaceutical industry to moderate on back of slowing growth from US given the relatively moderate ...
Read more: Indian pharma faces challenging times, revenue growth only 9.4% in Q2: ICRA